Assessment of myocardial viability using coronary zero flow pressure after successful angioplasty in patients with acute anterior myocardial infarction

Heart. 2003 Jan;89(1):71-6. doi: 10.1136/heart.89.1.71.

Abstract

Objectives: To investigate the relation between coronary flow reserve (CFR), coronary zero flow pressure (Pzf), and residual myocardial viability in patients with acute myocardial infarction.

Designs: Prospective study.

Setting: Primary care hospital.

Patients: 27 consecutive patients with acute anterior myocardial infarction.

Main outcome measures: F-fluorodeoxyglucose (FDG) positron emission tomography (PET) was used in 27 patients who underwent successful intervention within 12 hours of onset of a first acute anterior myocardial infarction. Within three days before discharge they had < 25% stenosis in the culprit lesion as determined by angiography 24 (3) days after acute myocardial infarction. Pzf and the slope index of the flow-pressure relation (SIFP) were calculated from the simultaneously recorded aortic pressure and coronary flow velocity signals at peak hyperaemia.%FDG was quantified by comparing FDG uptake in the infarct myocardium with FDG uptake in the normal myocardium.

Results: There was a correlation between %FDG and CFR, where y = -1.477x + 62.517, r = -0.072 (NS). There was also a correlation between %FDG and SIFP, where y = -0.975x + 60.542, r = -0.045 (NS), and a significant correlation between %FDG and Pzf, where y = -0.98x + 85.108, r = -0.696 (p < 0.001).

Conclusions: CFR does not correlate with FDG-PET at the time of postreperfusion evaluation of residual myocardial viability. The parameter that correlates best with residual myocardial viability is Pzf and this may be a useful index for predicting patient prognosis.

MeSH terms

  • Aged
  • Angioplasty, Balloon / methods
  • Blood Flow Velocity / physiology
  • Coronary Angiography / methods
  • Coronary Circulation / physiology*
  • Coronary Stenosis / complications
  • Coronary Stenosis / therapy
  • Echocardiography / methods
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / etiology
  • Myocardial Infarction / physiopathology*
  • Myocardial Infarction / therapy
  • Myocardial Reperfusion / methods
  • Myocardium*
  • Prospective Studies
  • Radiopharmaceuticals
  • Thrombolytic Therapy / methods
  • Tissue Survival*
  • Tomography, Emission-Computed, Single-Photon / methods
  • Vasodilator Agents / therapeutic use
  • Ventricular Dysfunction, Left / physiopathology

Substances

  • Radiopharmaceuticals
  • Vasodilator Agents
  • Fluorodeoxyglucose F18